Maria Giuseppina Baratta

An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma

Maria Giuseppina Baratta, Anna C. Schinzel, Yaara Zwang et al. · Proceedings of the National Academy of Sciences · 2014 · 168 citations · Full text

Medicine, Molecular Biology, Oncology +17

Dose-Dependent Inhibition of Thyroid Differentiation by RAS Oncogenes

Gabriella De Vita, Lisa Bauer, Vânia Maria Corrêa da Costa et al. · Molecular Endocrinology · 2004 · 63 citations · Full text

Medicine, Molecular Biology, Oncology +17

Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.

M M Lippman, W R Laster, Betty J. Abbott et al. · PubMed · 1975 · 46 citations

Medicine, Oncology, Pharmacology +7

Functional Inactivation of the Transcription Factor Pax8 through Oligomerization Chain Reaction

Barbara D’Andrea, Roberto Iacone, Tina Di Palma et al. · Molecular Endocrinology · 2006 · 28 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Oncogenic Ras Blocks the cAMP Pathway and Dedifferentiates Thyroid Cells Via an Impairment of Pax8 Transcriptional Activity

Maria Giuseppina Baratta, Immacolata Porreca, Roberto Di Lauro · Molecular Endocrinology · 2009 · 17 citations · Full text

Medicine, Cell Biology, Molecular Biology +17